RESUMO
Although crucial in improving health outcomes in the preterm infants, parenteral nutrition (PN) is not without risk, especially if handled improperly. A growing body of evidence suggests that components of PN admixtures, including lipid injectable emulsions (ILEs), are susceptible to degradation, including oxidation when exposed to light (ie, photo-oxidation), resulting in the production of reactive oxygen species. Infants, especially those born preterm, are considered more susceptible to consequences of oxidative stress than children and adults. Oxidative stress is associated with bronchopulmonary dysplasia, retinopathy of prematurity, necrotizing enterocolitis, and intestinal failure-associated liver disease. The American Society for Parenteral and Enteral Nutrition (ASPEN) assembled a working group to provide recommendations on clinical practice surrounding photoprotection of PN.This Position Paper reviews the scientific literature on the formation of quantifiable peroxides and other degradation products when PN admixtures and ILEs are exposed to light and reports adverse clinical outcomes in premature infants exposed to PN. Recommendations for photoprotection of PN admixtures and ILEs are provided, as well as the challenges in achieving complete photoprotection with the equipment, supplies, and materials currently available in the US. ASPEN and the authors understand that the full implementation of complete photoprotection may not currently be feasible given current product availability; recommendations provided in this paper serve to represent the goal to which to strive as well as to highlight the importance of product availability to achieve these practices. This paper has been approved by the ASPEN Board of Directors.
Assuntos
Displasia Broncopulmonar , Doenças do Prematuro , Criança , Nutrição Enteral , Humanos , Lactente , Recém-Nascido , Recém-Nascido Prematuro , Nutrição Parenteral , Estados UnidosRESUMO
BACKGROUND: In some studies, the dose of intravenous soybean oil (SO) has been associated with a decreased incidence of intestinal failure-associated liver disease. The effect of lipid sparing on neurodevelopment (ND) and growth remains unknown. This study investigated the impact of SO dose on ND and growth over the first 2 years of age in preterm neonates. MATERIALS AND METHODS: This is a single-site prospective follow-up study. Neonates with a gestational age ≤29 weeks were randomized to low-dose (LOW) or standard-dose (CON) SO. Bayley Scales of Infant Development III and anthropometric measurements were collected at approximately 6, 12, and 24 months corrected gestational age. RESULTS: Subjects were premature, with a mean (±SD) gestational age of 28 ± 1 and 27 ± 1 weeks (P = .3) for LOW and CON, respectively. Thirty subjects completed follow-up (LOW = 15, CON = 15). There were no differences for ND and growth outcomes when LOW was compared with CON, with the exception of a higher 12-month follow-up cognitive scaled score in the LOW group (P = .02). CONCLUSION: A reduced SO dose did not adversely affect ND or growth in this cohort of preterm neonates. However, larger studies are needed to determine the long-term safety of SO dose reduction before this strategy can be adopted.
Assuntos
Desenvolvimento Infantil/efeitos dos fármacos , Recém-Nascido Prematuro , Transtornos do Neurodesenvolvimento/prevenção & controle , Nutrição Parenteral/métodos , Óleo de Soja/uso terapêutico , Administração Intravenosa , Pré-Escolar , Relação Dose-Resposta a Droga , Feminino , Seguimentos , Humanos , Recém-Nascido , Masculino , Estudos Prospectivos , Óleo de Soja/administração & dosagem , Resultado do TratamentoRESUMO
OBJECTIVE: The aim of the study was to describe the nutritional provisions received by infants with surgical necrotizing enterocolitis (NEC) and the associated effects on short-term growth. METHODS: Through the Children's Hospitals Neonatal Database, we identified infants born ≤32 weeks' gestation with surgical NEC from 5 regional neonatal intensive care units for 4 years. Excluded infants had isolated intestinal perforation and died <14 days postoperatively. Infants were stratified by their median parenteral protein dose (low [LP] or high [HP] protein) for the first postoperative week. The primary outcome was postoperative weight growth velocity. Growth (weight, length, and head circumference [HC]) was measured and the effects related to protein dose were estimated using multivariable analyses. RESULTS: There were 103 infants included; the median parenteral protein dose received was 3.27âgâ·âkgâ·âday (LP: 2.80âgâ·âkgâ·âday; HP: 3.87âgâ·âkgâ·âday). Postoperative weight (11.5â±â6.5âgâ·âkgâ·âday) and linear growth (0.9â±â0.2âcm/wk) were similar regardless of dose (Pâ>â0.3 between groups for weight and length). Unadjusted and independent associations were identified with HC changes and HP dose (ßâ=â0.1âcm/wk, Pâ=â0.03) after adjusting for gestational age, the presence of severe bronchopulmonary dysplasia, short bowel syndrome, blood stream infection, severe intraventricular hemorrhage, small for gestational age, and calorie intake. Eventual nonsurvivors received 18% less protein and 14% fewer calories over the first postoperative month. CONCLUSIONS: Postoperative protein doses in infants with surgical NEC appear related to increases in HC. The influence of postoperative nutritional support on risk of adverse outcomes deserves further attention.
Assuntos
Proteínas Alimentares/administração & dosagem , Enterocolite Necrosante/terapia , Doenças do Prematuro/terapia , Recém-Nascido Prematuro/crescimento & desenvolvimento , Soluções de Nutrição Parenteral/administração & dosagem , Nutrição Parenteral/métodos , Cuidados Pós-Operatórios/métodos , Bases de Dados Factuais , Proteínas Alimentares/uso terapêutico , Enterocolite Necrosante/fisiopatologia , Feminino , Cabeça/crescimento & desenvolvimento , Humanos , Recém-Nascido , Doenças do Prematuro/fisiopatologia , Masculino , Soluções de Nutrição Parenteral/uso terapêutico , Resultado do Tratamento , Aumento de PesoRESUMO
BACKGROUND: Premature infants depend on intravenous fat emulsions to supply essential fatty acids and calories. The dose of soybean-based intravenous fat emulsions (S-IFE) has been associated with parenteral nutrition (PN)-associated liver disease. This study's purpose was to determine if low-dose S-IFE is a safe and effective preventive strategy for cholestasis in preterm neonates. MATERIALS AND METHODS: This is a multicenter randomized controlled trial in infants with a gestational age (GA) ≤29 weeks. Patients <48 hours of life were randomized to receive a low (1 g/kg/d) or control dose (approximately 3 g/kg/d) of S-IFE. The primary outcome was cholestasis, defined as a direct bilirubin ≥15% of the total bilirubin at 28 days of life (DOL) or full enteral feeds, whichever was later, after 14 days of PN. Secondary outcomes included growth, length of hospital stay, death, and major neonatal morbidities. RESULTS: In total, 136 neonates (67 and 69 in the low and control groups, respectively) were enrolled. Baseline characteristics were similar for the 2 groups. When the low group was compared with the control group, there was no difference in the primary outcome (69% vs 63%; 95% confidence interval, -0.1 to 0.22; P = .45). While the low group received less S-IFE and total calories over time compared with the control group (P < .001 and P = .03, respectively), weight, length, and head circumference at 28 DOL, discharge, and over time were not different (P > .2 for all). CONCLUSION: Compared with the control dose, low-dose S-IFE was not associated with a reduction in cholestasis or growth.
Assuntos
Colestase/prevenção & controle , Emulsões Gordurosas Intravenosas/administração & dosagem , Recém-Nascido Prematuro/crescimento & desenvolvimento , Óleo de Soja/administração & dosagem , Administração Intravenosa , Bilirrubina/metabolismo , Relação Dose-Resposta a Droga , Idade Gestacional , Humanos , Recém-Nascido , Tempo de Internação , Resultado do TratamentoRESUMO
OBJECTIVE: To identify small for gestational age (SGA) as an independent risk factor for parenteral nutrition-associated cholestasis (PNAC). STUDY DESIGN: In a case-control study, records of infants treated in the neonatal intensive care unit from 1994 through 2003 with gestational ages (GA) < 34 weeks and exposure to parenteral nutrition (PN) > or = 7 days were reviewed. The primary outcome was the incidence of cholestasis in infants who were SGA. Secondary outcomes included PN duration, age at full enteral nutrition (FEN) and incidence of late-onset sepsis, necrotizing enterocolitis (NEC) and bronchopulmonary dysplasia (BPD). Analysis was by t test, logistic regression, and chi2 analysis. RESULTS: Cases (n = 79) and control subjects (n = 152) had similar birth weights and GA (963 +/- 465 g versus 1090 +/- 463 g; 27 +/- 2 weeks versus 27 +/- 2 weeks; [mean +/- SD]). Of the infants who were SGA, 58% developed cholestasis (OR = 3.3, P < .01). Infants with cholestasis achieved FEN later (43 +/- 25 days versus 23 +/- 11 days) and had higher rates of sepsis (80% versus 34%), NEC (51% versus 7%), and BPD (65% versus 25%; P < .01). Of infants with cholestasis, infants who were SGA received fewer days of PN than infants who were appropriate for GA (49 +/- 24 days versus 68 +/- 36 days, P = .024). CONCLUSION: Being SGA is an independent risk factor for PNAC. Infants who are SGA require less PN for cholestasis to develop.